Abstract | PURPOSE: METHODS: Herpes simplex virus type 1 (strain CHR3) was inoculated onto bilateral scarified BALB/c corneas. Clinical scores on the corneas treated with A-5021 eyedrops were compared with those obtained from the treatment with 3% acyclovir eye ointment by slit lamp microscopy. Virus titers of the trigeminal ganglia and eyeballs were quantitated on Vero cell monolayers. Mice treated with saline or a white petroleum jelly were used as controls. RESULTS:
A-5021 eyedrops significantly suppressed both corneal epithelial and stromal lesions at all concentrations used. Clinical scores on the epithelium and stroma treated with 0.1% A-5021 were equivalent to those with 3% acyclovir treatment. When compared with the non- drug-treated control mice, virus titers in the eyeballs and trigeminal ganglia in A-5021- and acyclovir-treated mice were significantly less than those in controls. CONCLUSIONS:
A-5021 eyedrops, which are easily applied onto the affected cornea, ameliorated clinical scores and suppressed virus growth. It is a promising alternative treatment of herpetic keratitis.
|
Authors | Motoki Itahashi, Shiro Higaki, Daisuke Sugahara, Koji Sugioka, Tatsunori Deai, Kazumasa Takao, Kozaburo Hayashi, Yoshikazu Shimomura |
Journal | Cornea
(Cornea)
Vol. 27
Issue 3
Pg. 334-8
(Apr 2008)
ISSN: 0277-3740 [Print] United States |
PMID | 18362663
(Publication Type: Journal Article)
|
Chemical References |
- 9-((cis-1,2-bis(hydroxymethyl)cycloprop-1-yl)methyl)guanine
- Antiviral Agents
- Ophthalmic Solutions
- Guanine
- Acyclovir
|
Topics |
- Acyclovir
(analogs & derivatives, pharmacology)
- Animals
- Antiviral Agents
(pharmacology)
- Chlorocebus aethiops
- Disease Models, Animal
- Female
- Guanine
(analogs & derivatives, chemistry, pharmacology)
- Herpesvirus 1, Human
(drug effects, physiology)
- Keratitis, Herpetic
(prevention & control, virology)
- Mice
- Mice, Inbred BALB C
- Ophthalmic Solutions
(pharmacology)
- Trigeminal Ganglion
(virology)
- Vero Cells
(virology)
|